共济失调评估

最后审阅: 5 Oct 2024
最后更新: 12 May 2022

小结

鉴别诊断

常见

  • 酗酒性小脑变性
  • 缺血性脑卒中(小脑)
  • 缺血性脑卒中(脑干)
  • 小脑出血
  • 多发性硬化(Multiple sclerosis,MS)
  • Wernicke-Korsakoff 综合征
完整详情

不常见

  • 药物诱发性共济失调
  • 中毒性神经病
  • VonHippel-Lindau综合征
  • 缺氧性脑病变或热射病后遗症
  • 急性小脑炎
  • HIV
  • Gerstmann-Straussler综合征
  • Creutzfeldt-Jakob 综合征 (CJD)(共济失调变异型)
  • 小脑脓肿
  • Whipple 病
  • 神经梅毒
  • 后颅窝肿瘤
  • 颅椎连接异常
  • 副肿瘤性感觉神经病变
  • 共济失调伴抗谷氨酸脱羧酶(GAD)抗体
  • 乳糜泻
  • 肌阵挛-斜视眼阵挛综合征
  • 副癌性小脑变性
  • Miller-Fisher 综合征
  • 干燥综合征
  • 与单克隆丙球蛋白症有关的神经病
  • 甲状腺功能减退
  • 甲状旁腺功能减退
  • 维生素 B1 缺乏症
  • 维生素 B12 缺乏症
  • Friedreich 共济失调
  • 毛细血管扩张症
  • 共济失调伴动眼神经失用症1(AOA1)
  • 共济失调伴动眼神经失用症2(AOA2)
  • 伴维生素 E 缺乏的共济失调
  • 无 β 脂蛋白血症
  • 常染色体隐性遗传性痉挛性共济失调 Charlevoix-Saguenay 型
  • 因POLG1突变产生的共济失调
  • SCYL1 突变导致的共济失调
  • 与CoQ10缺陷有关的共济失调
  • 与代谢错误有关的共济失调
  • 脊髓小脑性共济失调1(SCA1)
  • 脊髓小脑性共济失调2(SCA2)
  • 脊髓小脑性共济失调3(SCA3)
  • 脊髓小脑性共济失调5(SCA5)
  • 脊髓小脑性共济失调6(SCA6)
  • 脊髓小脑性共济失调7(SCA7)
  • 脊髓小脑性共济失调8(SCA8)
  • 脊髓小脑性共济失调10(SCA10)
  • 脊髓小脑性共济失调11(SCA11)
  • 脊髓小脑性共济失调12(SCA12)
  • 脊髓小脑性共济失调13(SCA13)
  • 脊髓小脑性共济失调14(SCA14)
  • 脊髓小脑性共济失调15/16(SCA15/16)
  • 脊髓小脑性共济失调17(SCA17)
  • 脊髓小脑共济失调 18 (SCA 18)
  • 19/22 型脊髓小脑共济失调 (SCA 19/22)
  • 脊髓小脑性共济失调20(SCA20)
  • 脊髓小脑性共济失调21(SCA21)
  • 脊髓小脑性共济失调23(SCA23)
  • 脊髓小脑性共济失调25(SCA25)
  • 脊髓小脑性共济失调26(SCA26)
  • 脊髓小脑性共济失调27(SCA27)
  • 脊髓小脑性共济失调28(SCA28)
  • 脊髓小脑性共济失调29(SCA29)
  • 脊髓小脑性共济失调30(SCA30)
  • 脊髓小脑性共济失调31(SCA31)
  • 32 型脊髓小脑共济失调 (SCA 32)
  • 34 型脊髓小脑共济失调 (SCA 34)
  • 35 型脊髓小脑共济失调 (SCA 35)
  • 脊髓小脑共济失调 36 (SCA 36)
  • 37 型脊髓小脑共济失调 (SCA 37)
  • 38 型脊髓小脑共济失调 (SCA 38)
  • 40 型脊髓小脑共济失调 (SCA 40)
  • 齿状核红核苍白球丘脑底核萎缩(DRPLA)
  • 1 型周期性共济失调
  • 2型周期性共济失调
  • 脆性X震颤-共济失调综合征(FXTAS)
  • 线粒体细胞病
  • C型Niemann-Pick病(NP-C)
完整详情

撰稿人

作者

Vikram G Shakkottai, MD

Associate Professor of Neurology

University of Michigan

Ann Arbor

Michigan

利益声明

VGS has research funding through the National Institutes of Health, and the National Ataxia Foundation. He serves on the Medical Research Advisory Board of the National Ataxia Foundation. He is listed as an inventor on a patent filed by the University of Michigan for a therapeutic combination for cerebellar ataxia. He receives royalties from UptoDate Inc. He serves on the advisory board of uniQure.

鸣谢

Professor Vikram G Shakkottai would like to gratefully acknowledge Dr Barbara Kelly Changizi, Dr S.H. Subramony and Dr Hartmut Uschmann, previous contributors to this topic. SHS has received honoraria for lectures given from Athena Diagnostics Company. BKC and HU declare that they have no competing interests.

同行评议者

Thomas Klockgether, MD

Dean of Medical Faculty

Professor and Chair of Department of Neurology

University Hospital

Bonn

Germany

利益声明

TK declares that he has no competing interests.

Susan L. Perlman, MD

Clinical Professor of Neurology/Director

Ataxia Center and HD Center of Excellence

UCLA

Los Angeles

CA

利益声明

SLP is the co-author of 2 systematic reviews referenced in this topic.

内容使用需遵循免责声明